15th National Congress on Cardiovascular Update 17-20 September 2013 Tehran – Razi International Hall Organized by: Iranian Society of Atherosclerosis Main HALL Wednesday 18 Sep 2013 Registration Subjects Speakers Opening Ceremony Holy Quran H. Ranjbarnezhad National Anthem Welcome to participants M. Ghasemi (Chairman of Iranian Society of Atherosclerosis and Chairman of Congress) Report of scientific program of 15th congress on M. Eslami (Secretary of cardiovascular update Iranian Society of Atherosclerosis and Scientific Secretary of Congress) Risk factors of cardiovascular disease in 2013 A.R. Esteghamati (Professor of endocrinology of Tehran University of Medical Sciences) The status of cardiovascular disease in Iran F. Noohi (Chairman of Iranian Heart Association) Difficulties of treatment in Iran, now and future B. Moazami (Managing Director of Pars Hospital) Lunch & Exhibition Visit Wednesday 18 Sep. 2013 2nd Session: 14-15:30 Chairpersons : E. Nematipour, D. Kamalhedayat, Y. Nouzari, D. Akhlaghmoayed Subjects Speakers 14-14:30 Novel anticoagulants in comparison to warfarin M. Jabbarzadeh 14:30-15 Beyond syntax I and syntax II P. Serruys 15-15:30 Intervention left main disease and multivessel disease J. Fajadet Coffee Break & Exhibition Visit Panel Discussion: Atrial Fibrillation (AF) Moderator: Z. Emkanjoo embers: M. Haghjoo, A.R. Ghorbanisharif, M. Taherpour, A.F. Fazelifar, M. Jabbarzadeh hursday 19 Sep 2013 1st Session: 8-9:30 Chairpersons : A. Barzegar, H. Sezavar, A. Hakimpoor Subjects Speakers Diagnosis of diastolic LV dysfunction in outpatients clinic M. Moshkani 8:30 – 9 Management of STEMI by primary PCI OCT, IVUS and NIRS to guide stenting of complex lesions O. Hlinomaz Coffee Break & Exhibition Visit 2nd Session: 10:30-12:30 Bioresorbable Vascular Scaffold Symposium: The 4th Revolu on in Interven onal Cardiology Members: P.Serruys, J.Fajadet, M. Ghasemi, A.F. Zandparsa, S. Abdi Subjects Speakers 10:30-11:10 Most recent findings from ABSORB clinical trial program-what do these data P.Serruys mean for our patients 11:10-11:30 The importance of good vessel measurement M.A.Morel 11:30 -12:10 Real-world applicability with bioresorbable vascular scaffolds: J.Fajadet Indications today and indication for the future 12:10-12:30 Questions and Answers Lunch & Exhibition Visit 2:30 – 1 Panel Discussion: Challenging issues in multimodality imaging Moderator: R. Sattarzadeh Members: M. Toofan Tabrizi, N. Samiei, A. Sadeghpoor, M. Parsaei
Which modality should we choose for assessing myocardial viability? ( M. Toofan Tabrizi) Challenging issues in diastology ( N. Samiei) 3D versus 2D echocardiography, what are clinical implica ons now? ( A. Sadeghpoor) Constrictive pericarditis or restrictive cardiomyopathy? Which modality is more helpful? ( M. Parsaei) Acute aortic syndrome? Are we safe now? ( R. Sattarzadeh) Coffee Break & Exhibition Visit 15:30 - 16 16-17:30 Panel Discussion: Interventional Cardiology Moderator: A.M Hajzeynali Members: S. Abdi, J. Zamani, D. Kazemi Saleh, E. Nematipoor, M. Ghasemi Friday 20 Sep 2013 Cardiac Surgery Program 1st Session: 8:30-10:30 Prosthetic Valve Endocarditic (PVE) Chair persons: M. Mohraz, H. Ahmadi, M. A. Yousefnia, P.Nakhostin Davari, H. Radmehr Speakers 8:30-8:45 Etiology, Pathogenesis and classification M.Jebelli 8:45-9:00 Clinical Manifestations and diagnosis A. Bakhshandeh 9:00-9:15 Anticoagulation therapy in PVE J. Bagheri 9:15 - 9:30 Imaging diagnosis and echocardiography R. Sattarzadeh 9:30-10:00 Management and medical treatment of PVE M. Rasolinejad, Z. Ahmadinezhad 10:00-10:15 Surgical treatment M. Salehi 10:15 - 10:30 Questions and Answers 10:30-11 Coffee Break & Exhibition Visit 11:00 - 13:00 2nd Session: Endovascular and Cardiac Surgery Chair persons: M.H. Mandegar, A.A. Karimi, M.Marzban, M. Mirhoseini, M. Ghasemi Speakers 11:00-11:20 TAVI (Film and case presentation) K.Abbasi 11:20 - 11:40 EVAR (Film and case presentation) A.M Hajzeinali 11:40 - 12:00 Iliac Aneurysms and Endovascular J.Salimi 12:00-12:30 Hybrid procedure and TEVAR (Film) M. Shirzad 12:30 - 13 Questions and Answers Lunch & Exhibition Visit
ABSTRACT: In response to a request by Barr Laboratories to market their “emergency contraceptive” Plan B across the counter, the Food and Drug Administration (FDA) held a public hearing. Objections to the proposal included: (1) A considerable increase in tubal pregnancies following ingestion of Plan B was found in U.K., prompting a warning to physicians. Lack of medical supervision when provid
RIGHTFOOT , The Brewery Business Centre, Bells Yew Green, Frant, East Sussex TN3 9BD E. ben@rightfoot-uk.com P. +44 (0)1892 750900 www .rightfoot-uk.com Kit-List When preparing for Kilimanjaro, there is a difficult balance to strike between packing enough so that you have all you need, and packing too much and therefore carrying too much weight. Bear in mind in particular that th